The reasons for ineffectiveness of H2-receptor antagonists in gastroesophageal reflux disease
- 30 June 1995
- journal article
- other
- Published by Elsevier in Gastroenterology
- Vol. 108 (6) , 1958-1959
- https://doi.org/10.1016/0016-5085(95)90179-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: “For whom the bell tolls”Gastroenterology, 1994
- Comparison of acid inhibition by either oral high‐dose ranitidine or omeprazoleAlimentary Pharmacology & Therapeutics, 1994
- The eflects of 300 mg ranitidine at night, twice daily and four times daily on intragastric acidity in normal subjectsAlimentary Pharmacology & Therapeutics, 1993
- Twenty-four-Hour Control of Gastric Acidity by Twice-Daily Doses of Placebo, Nizatidine 150 mg, Nizatidine 300 mg, and Ranitidine 300 mgThe Journal of Clinical Pharmacology, 1993
- Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease.Gut, 1992
- Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s.Alimentary Pharmacology & Therapeutics, 1989
- The Time Pattern of Gastroesophageal RefluxScandinavian Journal of Gastroenterology, 1988
- Daytime gastro-oesophageal reflux is important in oesophagitis.Gut, 1987
- Mechanisms of Gastroesophageal Reflux in Patients with Reflux EsophagitisNew England Journal of Medicine, 1982